Heart Rhythm

Hearts should have normal rhythm to their beats, but when these beats are out of synch, it causes inefficient pumping of blood. Irregular heart arrhythmias occur when the electrical signals that coordinate the heart's beats do not work properly. This can cause beats that are too fast (tachycardia), or too slow (bradycardia). Tachycardias include atrial fibrillation (AFib), supraventricular tachycardia, ventricular fibrillation, and ventricular tachycardia (VT). Bradycardias include sick sinus syndrome and conduction block. Electrophysiology arrhythmia treatments include medications, life style changes, and the EP lab interventions of catheter ablation, and implantable pacemakers or defibrillators.

Boston Scientific to purchase Elutia’s drug-eluting envelope business for $88M
The FDA-cleared EluPro bioenvelope delivers two antibiotics to patients over an extended period of time after they receive an implantable pacemaker or defibrillator to cut infection rates.
Exploring the link between left ventricular diastolic function and AFib
Evaluating LVDF with echocardiography or AI-powered electrocardiography can help identify individuals at an increased risk of developing atrial fibrillation, according to new data presented at the ASE 36th Annual Scientific Sessions.
Q&A: Cardiologist explores CMS proposal to cover cardiac ablations performed in ambulatory surgical centers
CMS has proposed a policy shift that would allow cardiac ablation procedures to be performed in ambulatory surgical centers. Arash Aryana, MD, PhD, a veteran cardiac electrophysiologist, explained why he is "extremely encouraged" by this proposal, highlighting several potential benefits.
FDA clears Kardium Globe pulsed field ablation system
It is the only integrated system that combines high-density mapping and PFA in a single device. The system uses a 122-electrode spherical array to enable rapid, single-shot pulmonary vein isolation, helping to streamline workflows.
Philips launches smart telemetry platform for cardiac monitoring
Care teams can face alarm and cognitive overload, with an average of 350 alarms going off per patient per day. But Philips' new telemetry platform streamlines alarm management, delivers data-driven insights and automates clinical tasks—with operational simplicity and networking options.

The best part of waking up? Coffee may protect against AFib

A regular intake of up to 300 mg of coffee a day appears to be safe and may even be protective against heart rhythm disorders, including atrial fibrillation (AFib), according to a new review published April 16 in the Journal of the American College of Cardiology.

Researchers: Online ICD message board littered with inaccuracies

Only half of medical advice on an online message board dedicated to implanted cardiac defibrillators (ICDs) appears to be accurate, according to preliminary research presented April 7 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018.

AFib ablation strategies for ‘normal’ hearts also work for CHD survivors

Atrial fibrillation (AFib) ablation techniques used on individuals without cardiac abnormalities can be safely applied to adults with congenital heart disease (CHD), according to a new study in JACC: Clinical Electrophysiology. But in many cases, multiple ablation procedures are needed to boost the chances of arrhythmia-free survival.

Ablation procedure burns away puppy’s heart arrhythmia

A 6-month-old German Shepherd was the beneficiary of a successful cardiac ablation at Cornell University Hospital for Animals, one of only two centers in the U.S. that regularly offers the procedure for dogs.

AFib after CABG linked to minimal long-term stroke risk

Patients who developed new-onset postoperative atrial fibrillation (POAF) after coronary artery bypass graft (CABG) surgery showed a 33 percent reduced risk of thromboembolism long-term when compared to those with nonsurgical AFib, according to a study published March 28 in JAMA Cardiology.

BioSig Announces Submission of FDA 510(k) Application for PURE EP(TM) System

Santa Monica, CA, March 28, 2018 — BioSig Technologies, Inc. (OTCQB: BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA) for its first product, PURE EP(TM) System.

Depression may increase the risk for AFib

New research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2018 suggests individuals with depression may have an increased risk of developing atrial fibrillation (AFib).

ICD implantation boosts survival after cardiac arrests with reversible causes

Current clinical guidelines recommend implantable cardioverter-defibrillators (ICDs) in survivors of sudden cardiac arrest (SCA), except when the cause of the SCA is deemed reversible. But a new study in Circulation: Arrhythmia and Electrophysiology demonstrates that many of these patients gain a survival benefit from ICDs as well.

Heart Rhythm

Boston Scientific to purchase Elutia’s drug-eluting envelope business for $88M

Exploring the link between left ventricular diastolic function and AFib

Q&A: Cardiologist explores CMS proposal to cover cardiac ablations performed in ambulatory surgical centers

FDA clears Kardium Globe pulsed field ablation system

Philips launches smart telemetry platform for cardiac monitoring